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Chronic unilateral ureteral obstruction is a well characterized
model of renal injury leading to tubulointerstitial fibrosis and
distinct patterns of cell proliferation and apoptosis in the
obstructed kidney. In this study we assessed the contribution
of the mitogen activated protein kinase (MAPK)-ERK1/2
and the phosphatidylinositol 3 kinase (PI3K)-Akt pathways
to early renal changes following unilateral obstruction.
Increased activation of small Ras GTPase and its downstream
effectors ERK1/2 and Akt was detected in ligated kidneys.
The use of specific pharmacological inhibitors to either
ERK1/2 or Akt activation led to decreased levels of fibroblast-
myofibroblast markers in the interstitium while inhibition
of PI3K reduced the number of proliferating cells and
the amount of interstitial extracellular matrix deposition.
Treatment with an ERK1/2 inhibitor diminished the number
of apoptotic tubule and interstitial cells. Our results suggest
a role for the MAPK-ERK1/2 and PI3K-Akt systems in early
changes induced by ureteral obstruction and that inhibition
of these signaling pathways may provide a novel approach
to prevent progression of renal fibrosis.
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End-stage renal disease is one of the most prevalent complica-
tions of hypertension, diabetes, and intrinsic renal diseases.1
Depending on the pathology, progressive accumulation of
extracellular matrix can occur in the glomeruli (glomerulo-
sclerosis) and/or the interstitial space (tubulointerstitial
fibrosis). Several studies suggest that it is the severity of
tubulointerstitial fibrosis that best correlates with the risk for
renal failure progression.2 Chronic unilateral ureteral obstruc-
tion (UUO) is a well-characterized model of renal injury
leading to tubulointerstitial fibrosis and distinct patterns of cell
proliferation and apoptosis in the obstructed kidney.3 Inter-
stitial proliferation has been related to development of
tubulointerstitial renal fibrosis as obstruction induces differ-
entiation of interstitial fibroblasts into a-smooth muscle actin
(a-SMA)-positive myofibroblasts,4 the principal effector cells
responsible for the excess of interstitial extracellular matrix
accumulation under pathologic conditions.5 Apoptosis of
tubular epithelial cells has been implicated in the progressive
renal atrophy that follows experimental obstruction.6,7 Both
apoptosis and tubulointerstitial fibrosis culminate in a loss of
renal mass and kidney dysfunction in obstructive nephropathy.3
Mechanisms by which UUO gives rise to renal damage are
gradually being elucidated. They include mechanical stretch
from urine accumulation and subsequent tubular disten-
sion,8 hypoxia caused by reduced renal perfusion,3 increased
oxidative stress,9 and upregulation of inflammatory factors
such as monocyte chemoattractant peptide,10 vasoconstric-
tors including angiotensin II11,12 and endothelin,13 as well as
macrophage-derived cytokines, especially the profibrotic
transforming growth factor-b1,14 which together contribute
to obstruction-induced renal damage. Most of these factors
mainly act via two types of membrane receptors: G protein-
coupled receptors and tyrosine kinase receptors whose
downstream signaling involves a range of effectors, including
the Ras-mitogen-activated protein kinase (MAPK)/extra-
cellular-regulated signal kinases 1 and 2 (ERK1/2) phos-
phorylation and the phosphatidyl inositol 3 kinase (PI3K)–
Akt pathway activation.15 Once active, ERK1/2 and Akt
control fundamental cellular processes such as the cell cycle
and cell survival.16,17
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It has been demonstrated that ERK1/2 and Akt are activated
in the kidneys of diabetic mice18 and rats with glomerulo-
nephritis.19,20 Recently, ERK activation has been reported after
UUO in rats.21,22 However, to date no reports have examined
the effect of in vivo inhibiting ERK1/2 or Akt activation on
kidneys of mice submitted to obstructive nephropathy.
In the present study, we aimed to test whether ERK1/2 and
Akt are activated in the early phase of an experimental model
of tubulointerstitial renal fibrosis induced by 3 days of UUO
in C57BL/6J mice. In addition, we assessed the contribution
of either Ras downstream pathways, MAPK–ERK1/2 or
PI3K–Akt, to the obstruction-induced renal alterations by
in vivo administration of either U0126 or LY 294002 as
corresponding inhibitors of ERK1/2 and Akt activation.
RESULTS
Early renal changes after UUO in mice
Three days after UUO, neither contralateral non-ligated (NL)
kidneys nor sham-operated (SO) kidneys exhibited morpho-
logical alterations. In contrast, ligated (L) kidneys showed
typical features of early hydronephrosis including medullar
compression toward cortex, flattening of both inner medulla
and papillae, together with partial tubular dilation and
flattened epithelium in affected tubules mainly circumscribed
to the outer cortex.
Figure 1a shows immunohistochemical images for the
early fibrosis marker fibronectin in SO, L, and NL kidneys.
SO and NL kidneys presented a slight expression of fibro-
nectin that was limited to epithelial basement membranes
and around the endothelium of both large vessels and
capillaries, whereas no staining was found in the tubular
interstitium. Ligated kidneys showed an intense interstitial
expression of fibronectin accompanied by a strong sub-
endothelial and adventitial staining in large vessels. In
agreement with morphometrical quantifying of interstitial
fibronectin expression (Figure 1b), western blot analysis
revealed significant higher levels of fibronectin in L kidneys
than in NL or SO kidneys (Figure 1c and d).
Figure 2 include immunohistochemical images, morpho-
metrical quantifying, and western blot analysis for the
extracellular matrix protein collagen type I in SO, L, and
NL kidneys. In SO animals, collagen type I staining was
restricted to peritubular and adventitial areas of renal cortex
with a very scarce immunostaining detected. Collagen I
distribution in NL kidneys was similar to that in SO kidneys,
whereas a marked staining was observed in peritubular and
pericapillary interstitial areas of L kidneys (Figure 2a), as
confirmed by quantitative immunohistochemical determina-
tion of interstitial collagen I (Figure 2b). Western blot
analysis revealed significant higher levels of collagen I in
L kidneys than in NL or SO kidneys (Figure 2c and d).
The presence of interstitial cells expressing mesenchymal
markers such as a-SMA and vimentin has been described as
additional source of generating fibroblast–myofibroblasts
in obstructive nephropathy.4 The expression of a-SMA was
therefore assessed in renal interstitium (Figure 3) as a marker
of myofibroblasts, the principal cells involved in extracellular
matrix production under pathological conditions.4 Alpha-
SMA immunostaining was restricted to the smooth muscle of
arterial walls and absent in peritubular interstitium of both
SO and NL kidneys (Figure 3a). In contrast, a-SMA staining
was additionally expressed by interstitial cells of L kidneys
(Figure 3a) as confirmed by immunohistochemical quantify-
ing of interstitial a-SMA (Figure 3b). Significant higher levels
of a-SMA were also detected by western blot in L kidneys
when compared with NL or SO kidneys (Figure 3c and d).
As additional feature of the presence of profibrotic cells,
vimentin immunodetection was performed in renal tissues.
In SO and NL kidneys, vimentin-positive immunostaining
was restricted to glomeruli and vascular walls, and no
staining was detected in the renal interstitium (Figure 4a).
However, like cells expressing a-SMA, numerous vimentin-
positive cells were found in peritubular interstitium of L
kidneys (Figure 4a and b). Western blot analysis also revealed
increased vimentin expression in L when compared with NL
or SO kidneys (Figure 4c and d). In addition, the number of
CD68-positive cells was determined to assess the contribu-
tion of macrophages to the whole of cellular components in
the interstitial cortex after UUO. As Figure 5 shows, CD68-
positive cells were almost absent in SO and NL kidneys.
Immunodetection of CD68 was rarely observed in L kidneys,
appearing restricted to perivascular areas and in a markedly
lower number than in a-SMA- or vimentin-positive cells.
Proliferation rate of renal cells was assessed by count of
nuclear immunostaining of Ki-67 protein (Figure 6a and b),
the expression of which is strictly associated with proliferative
process.23 Kidneys of SO mice presented scarce positive
Ki-67 nuclei in both tubules and interstitium. Ligated
kidneys showed a significantly higher number of Ki-67-
stained tubular and interstitial cells when compared with
kidneys of SO mice.
Tubular cell apoptosis is a prominent feature of UUO.6
As caspases serve as effector molecules of apoptotic program,
and activated caspase-3 is well known as the principal
executioner caspase24 with a central role described for this
enzyme in UUO-induced renal cell apoptosis in rats,6 we
have assessed the number of renal cells initiating apoptosis by
activated caspase-3 immunostaining. Renal cells stained
with cleaved caspase-3 were almost absent in SO kidneys
(Figure 6a). Several tubules of L kidneys appeared with all
the epithelial cells positive for cleaved caspase-3, usually
coinciding with dilated tubules (Figure 6a), and counting of
stained tubules revealed a significant increase in relation to
SO animals (7.5±0.5 tubules per field in L kidneys vs o0.1
tubules per field in SO animals; Po0.05). When compared
with SO kidneys, an appreciable increase was also detected in
L kidneys for the area occupied by caspase-3-positive
interstitial cells, as confirmed by quantitative immunohisto-
chemical determination (Figure 6c). We have also detected
DNA fragmentation using the terminal uridine deoxynucleo-
tidyl transferase dUTP nick-end labeling (TUNEL) assay.
Tubular cell nuclei stained with this method were almost
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absent in SO kidneys, where only scarce interstitial-labeled
nuclei were detected (Figure 6a). In contrast, abundant
stained nuclei were found both in tubular epithelia, mainly in
dilated tubules, and in interstitium of L kidneys (Figure 6a).
No changes in fibronectin, collagen type I, a-SMA,
vimentin, Ki-67, or activated caspase-3 expression were
found in kidneys of SO animals receiving the vehicle
dimethyl sulfoxide (DMSO) when compared with control
SO kidneys (data not shown). In comparison with UUO non-
treated animals, kidneys of UUO mice treated with DMSO
showed no significant differences for Ki-67 and activated
caspase-3 immunostaining (data not shown) as well as for
fibronectin, collagen type I, a-SMA, and vimentin expression
(Figures 1c,d, 2c,d, 3c,d and 4c,d, respectively).
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Figure 1 | Renal detection of fibronectin 3 days after surgery. (a) Representative images of immunohistochemistry for fibronectin in
kidneys of sham-operated (SO), contralateral non-ligated (NL), and ligated (L) groups, and (b) corresponding morphometrical quantifying of
fibronectin-immunostained areas in the renal interstitium. Bar¼ 50 mm in all panels. Bars represent the mean±s.e.m. of values obtained
after quantitative image analysis (see Materials and Methods). (c and d) Representative western blot analysis of fibronectin expression
in kidneys of SO, NL, and L groups. Bars represent the mean±s.e.m. of optical density of signals (n¼ 4 samples per group). Vehicle-control
animals received the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the corresponding inhibitors
of ERK1/2 and Akt activation, both dissolved in DMSO. *Po0.05 vs SO kidneys. #Po0.05 vs L untreated group.
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Activation of the Ras signaling effectors ERK1/2 and Akt after
UUO
We next assessed, by detection of phosphorylated forms of
ERK1/2 (pERK1/2) and Akt (pAkt), whether the MAP-
K–ERK1/2 and PI3K–Akt cascades initiated by Ras activation
were also activated after UUO. Phosho-ERK1/2 immuno-
staining was limited to a faint interstitial expression in the
cortex of SO and NL kidneys (Figure 7a). An intense staining
for pERK1/2 was found in cortical tubulointerstitial areas of
L kidneys (Figure 7a). Western blot analysis supported
immunohistochemical data as it showed the presence of the
active phosphorylated form of ERK1/2 in renal lysates from
all experimental groups, with significant higher levels of
pERK1/2 in L kidneys than in NL or SO kidneys (Figure 7b).
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Figure 2 | Renal detection of collagen I 3 days after surgery. (a) Representative images of immunohistochemistry for collagen I in kidneys
of sham-operated (SO), contralateral non-ligated (NL), and ligated (L) groups, and (b) corresponding morphometrical quantifying of collagen
I-immunostained areas in the renal interstitium. Bar¼ 50mm in all panels. Bars represent the mean±s.e.m. of values obtained after
quantitative image analysis (see Materials and Methods). (c and d) Representative western blot analysis of collagen I expression in kidneys of
SO, NL, and L groups. Bars represent the mean±s.e.m. of optical density of signals (n¼ 4 samples per group). Vehicle-control animals
received the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the corresponding inhibitors of
ERK1/2 and Akt activation, both dissolved in DMSO. *Po0.05 vs SO kidneys. #Po0.05 vs L untreated group.
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Phospho-Akt immunostaining showed a strong granular
expression in proximal convoluted tubule cells with the cyto-
plasmic signal localized to basolateral and medial cell area
and scarce or absent staining in both distal and collecting
tubules of SO kidneys (Figure 7a). The same pattern of
distribution was observed in NL kidneys but with stronger
cytoplasmic expression than in SO kidneys in proximal
tubules. Ligated kidneys showed an intense expression of
pAkt in normal proximal tubular cells, with staining evenly
distributed throughout the cytoplasm in most cases. In
contrast, low levels of pAkt expression were detected in
epithelial tubular cells as a typical feature of altered tubules
(Figure 7a). Western blot analysis revealed higher pAkt signal
in L kidneys than in NL or SO kidneys (Figure 7c). In
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Figure 3 | Renal detection of a-smooth muscle actin (a-SMA) 3 days after surgery. (a) Representative images of immunohistochemistry
for a-SMA in kidneys of sham-operated (SO), contralateral non-ligated (NL), and ligated (L) groups, and (b) corresponding morphometrical
quantifying of a-SMA-immunostained areas in the renal interstitium. Bar¼ 50mm in all panels. Bars represent the mean±s.e.m. of
values obtained after quantitative image analysis (see Materials and Methods). (c and d) Representative western blot analysis of a-SMA
expression in kidneys of SO, NL, and L groups. Bars represent the mean±s.e.m. of optical density of signals (n¼ 4 samples per group).
Vehicle-control animals received the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the
corresponding inhibitors of ERK1/2 and Akt activation, both dissolved in DMSO. *Po0.05 vs SO kidneys. #Po0.05 vs L untreated group.
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addition, total Akt levels were higher in L kidneys than in
NL or SO kidneys as demonstrated by western and northern
blot analysis (Figure 8a and b, respectively).
No differences in ERK1/2 or Akt phosphorylation were
detected in kidneys of SO animals receiving DMSO in
comparison with kidneys of control SO animals (data not
shown). The solvent had no significant effects on pERK1/2
renal expression in UUO mice when compared with the
respective control non-treated animals (Figure 7b). Admin-
istration of DMSO reduced the obstruction-induced Akt
phosphorylation (Figure 7c).
As both MAPK–ERK1/2 and PI3K–Akt are downstream
effectors of the small Ras GTPase, we assessed Ras activation
after UUO. Activated Ras, measured by western blot as
the ratio Ras-GTP/total Ras, was markedly higher in the
L kidneys compared with NL kidneys or kidneys of SO mice
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Figure 4 | Renal detection of vimentin 3 days after surgery. (a) Representative images of immunohistochemistry for vimentin in kidneys
of sham-operated (SO), contralateral non-ligated (NL), and ligated (L) groups, and (b) corresponding morphometrical quantifying of
vimentin-immunostained areas in the renal interstitium. Bar¼ 50mm in all panels. Bars represent the mean±s.e.m. of values obtained
after quantitative image analysis (see Materials and Methods). (c and d) Representative western blot analysis of vimentin expression in
kidneys of SO, NL, and L groups. Bars represent the mean±s.e.m. of optical density of signals (n¼ 4 samples per group). Vehicle-control
animals received the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the corresponding
inhibitors of ERK1/2 and Akt activation, both dissolved in DMSO. *Po0.05 vs SO kidneys. #Po0.05 vs L untreated group.
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(Figure 7d). No differences were found between NL and SO
kidneys in terms of Ras activation.
Effect of ERK1/2-activation inhibitor on renal changes after
ureteral obstruction
Our next purpose was to assess whether the inhibition of the
MAPKK (MEK)1/2–ERK1/2 signaling pathway could mod-
ulate the expression of the early fibrosis markers fibronectin
and collagen I in kidneys submitted to 3 days of obstruction.
Western blot analysis revealed that treatment with U0126
markedly reduced the UUO-induced ERK1/2 activation in L
kidneys (Figure 7b). Administration of U0126 or DMSO did
not significantly modify the UUO-induced increase in
fibronectin levels (Figure 1c). Furthermore, immunohisto-
chemistry for fibronectin demonstrated a similar distribution
in tubulointerstitial areas of both DMSO- and U0126-treated
L kidneys (Figure 1a), and immunohistochemical quantifying
also revealed that administration of U0126 does not modify
the amount of interstitial fibronectin staining (Figure 1b).
Similar results were obtained for collagen I detected by
western blot, immunohistochemistry, or semiquantitative
immunohistochemical analysis (Figure 2).
Administration of U0126 prevented the UUO-induced
a-SMA upregulation as demonstrated by western blot ana-
lysis (Figure 3c), whereas no significant effect was observed
on animals receiving only DMSO. In agreement, reduced
a-SMA immunostaining was found in the tubulointerstitial
areas of L kidneys of U0126-treated mice when compared
with L kidneys of DMSO-treated animals (Figure 3a).
Quantifying of interstitial a-SMA immunostaining revealed
a significantly reduced staining in L kidneys of animals
treated with U0126 when compared to L kidneys of animals
receiving only the vehicle (Figure 3b).
Immunohistochemical analysis demonstrated that the
number of vimentin-positive interstitial cells was markedly
lower in L kidneys of U0126-treated mice than in L kidneys
of DMSO-treated animals (Figure 4a). Morphometrical
quantifying revealed that vimentin-stained area was signifi-
cantly lower in L kidneys of U0126-treated mice than in
L kidneys of DMSO-treated animals (Figure 4b). Western
blot data show that obstruction-induced increase in vimentin
expression was completely prevented by treatment with
U0126, whereas no effect was observed for the solvent DMSO
(Figure 4c).
We have also evaluated the effect of inhibiting MEK1/2–
ERK1/2 signaling pathway on renal cell proliferation, acti-
vated caspase-3 staining, and TUNEL labeling in obstructed
kidneys (Figure 6). Treatment with U0126 induced a slight
decrease in the number of Ki-67-stained nuclei in obstructed
interstitium whereas the number of stained tubular nuclei
was reduced around 50% in comparison with mice receiving
only the vehicle, though these differences did not reach
statistical significance (Figure 6a and b).
In L kidneys, U0126 induced a significant decrease in the
number of tubules stained with activated caspase-3 when
compared with DMSO-treated animals (3.7±0.4 tubules per
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Figure 5 | Renal detection of CD68 3 days after surgery. Representative images of immunohistochemistry for CD68 in kidneys of
sham-operated (SO), contralateral non-ligated (NL), and ligated (L) groups. Bar¼ 20mm in all panels. Vehicle-control animals received
the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the corresponding inhibitors of ERK1/2 and
Akt activation, both dissolved in DMSO.
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field in U0126-treated animals vs 7.8±0.4 tubules per field in
DMSO-treated animals; Po0.05). This result correlated with
TUNEL assays, which confirmed a decrease in the stained cell
nuclei in L kidneys after U0126 treatment (Figure 6a). In
contrast to L kidneys of DMSO-treated mice showing the
whole tubular epithelia of dilated tubuli strongly stained for
cleaved caspase-3, stained tubules of U0126-treated mice
presented only a faint staining (Figure 6a). Furthermore,
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Figure 6 | Renal detection of Ki-67, cleaved caspase-3, and TUNEL staining 3 days after surgery. (a) Representative renal images of
immunohistochemistry for Ki-67, cleaved caspase-3, and TUNEL assay in kidneys of sham-operated (SO) and ligated (L) groups. Bar¼ 50mm for
panels of Ki-67 and 20mm for panels of caspase-3 and TUNEL staining. (b) Number of either interstitial or tubular Ki-67-positive cells
in the kidneys of SO and L groups. Bars represent the mean±s.e.m. of stained cells. (c) Morphometrical quantifying of cleaved caspase-3-
immunostained areas in the renal interstitium. Bars represent the mean±s.e.m. of values obtained after quantitative image analysis (see Materials
and Methods). Vehicle-control animals received the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the
corresponding inhibitors of ERK1/2 and Akt activation, both dissolved in DMSO. *Po0.05 vs SO kidneys. #Po0.05 vs L untreated group.
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morphometrical quantifying revealed that L kidneys treated
with U0126 presented a significant lower interstitial area
stained for caspase-3 than L kidneys of DMSO-treated mice
(Figure 6c).
Effect of PI3K pathway inhibition on renal changes after
ligature
To assess the role of Akt activation in obstruction-induced
early renal damage, mice received the specific PI3K inhibitor
LY 294002. Western blot analysis revealed that administration
of LY 294002 markedly reduced the obstruction-induced Akt
activation but not total Akt (Figures 7c and 8a, respectively).
PI3K inhibitor additionally blunted in a significant manner
the ligation-induced increase in both fibronectin (Figure 1d)
and collagen I levels (Figure 2d). Immunohistochemistry, as
well as corresponding morphometrical quantifying, revealed
a significantly lower area occupied by interstitial fibronectin
in L kidneys of LY 294002-treated mice than in L kidneys of
DMSO-treated animals (Figure 1a and b), with similar results
obtained for collagen I expression (Figure 2a and b).
Moreover, administration of LY 294002 blunted the obstruc-
tion-induced a-SMA expression in L kidneys to levels
nonsignificantly different from SO mice, as western blot
demonstrated (Figure 3d). Reduced tubulointerstitial areas
stained with a-SMA were also detected in obstructed kidneys
of LY 294002-treated mice when compared with DMSO-
treated animals (Figure 3a and b).
Similar observations were made for vimentin detection
in obstructed kidneys of mice receiving PI3K inhi-
bitor. Immunohistochemical analysis and its corresponding
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Figure 7 | Renal detection of activated forms of ERK1/2, Akt, and Ras 3 days after surgery. (a) Representative immunohistochemical
images of activated ERK1/2 (pERK1/2) and Akt (pAkt) in kidneys of sham-operated (SO), contralateral non-ligated (NL), and ligated (L) groups
3 days after surgery. Asterisk indicates the presence of dilated tubules lacking immunostaining. Bar¼ 50 mm in all panels.
(b–d) Representative western blot analysis of pERK1/2, pAkt, and activated Ras (measured as the ratio Ras-GTP/total Ras) expression
in kidneys of SO, NL, and L groups 3 days after surgery (n¼ 4 samples per group, except for Ras detection where at least seven samples per
group were used). Bars represent the mean±s.e.m. of the optical density of signals. *Po0.05 vs SO kidneys. Vehicle-control animals
received the solvent dimethyl sulfoxide (DMSO). U0126 and LY 294002 groups respectively received the corresponding inhibitors of
ERK1/2 and Akt activation, both dissolved in DMSO.
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interstitial quantifying revealed that the number of vimentin-
positive cells were markedly lower in L kidneys of LY 294002-
treated mice than L in kidneys of DMSO-treated animals
(Figure 4a and b). Western blot also demonstrated that
administration of LY 294002 clearly reduced the vimentin
content in L kidneys, detecting similar levels to those found
in SO animals (Figure 4d).
We have also assessed the effect of inhibiting the PI3K–Akt
pathway on proliferation, caspase-3 activation, and TUNEL
staining in L kidneys. Inhibition of Akt activation signifi-
cantly diminished the obstruction-induced increased number
of both tubular and interstitial Ki-67-stained nuclei with
respect to DMSO-L kidneys (Figure 6a and b). Immuno-
histochemistry for activated caspase-3 showed a similar
number of stained tubules after LY 294002 or vehicle admin-
istration in obstructed kidneys (7.7±0.4 for LY 294002 vs
7.8±0.4 tubules per field for DMSO; nonsignificant).
TUNEL staining did not show differences in the abundance
of tubular stained cell nuclei when images of L kidneys
from DMSO- and LY 294002-treated mice were compared
(Figure 6a). As morphological quantifying demonstrated,
similar interstitial areas occupied by caspase-3 immuno-
staining were detected in obstructed kidneys of DMSO- and
LY 294002-treated animals (Figure 6c). Though no effects on
the number of tubular and interstitial cells stained for cleaved
caspase-3 were found, caspase-3-stained dilated tubules
showed higher damage degree in kidneys of LY 294002-
treated animals than in kidneys of DMSO-treated mice as
demonstrated by the loss of brush border as well as the
flattened and disorganized epithelial tubular cells with
frequent tubular denudation (Figure 6a).
DISCUSSION
Early renal changes in obstructive nephropathy
In this work, we were interested in the initial mechanisms
related to renal damage induced by UUO. Previous studies
have already described renal molecular changes as early as
30 min22 and 6 h12 after ureteral ligation. We have observed
that renal damage is manifested within 3 days post-
obstruction by both tubular and interstitial alterations. At
this early stage, atrophy and tubular dilation, together with
simplification and proliferation of tubular epithelial cells,
appeared as pathological features of certain tubules in
obstructed kidneys. Our data also showed that tubular cell
apoptosis, assessed by TUNEL assay and immunohisto-
chemistry for cleaved caspase-3, was very abundant in
L kidneys, whereas only a moderate but significant increase
in the amount of interstitial cells expressing cleaved caspase-3
was observed in obstructed kidneys. These data are in
agreement with the proposed role for apoptosis in post-
obstructive renal damage.6,7
Fibronectin was included as a marker of early renal fibrosis
as previous studies demonstrated that a preformed fibro-
nectin matrix is essential for fibroblasts to form a collagen
network,25 and an important role in promoting matrix
assembly has been described for this protein allowing cells to
attach to the matrix.26 The increased levels of fibronectin and
collagen that we have found in obstructed kidneys revealed
that renal changes related to early fibrotic process can be
detected as early as 3 days post-UUO. By immunodetection
of both a-SMA and vimentin, our data also demonstrate that
essential changes associated with fibroblast/myofibroblast
appearance occur in the obstructed interstitium. In contrast
to SO and NL kidneys, where interstitial expression of
vimentin or a-SMA was not detected, abundant interstitial
cells expressing vimentin or a-SMA were found in the
interstitium of L kidneys. CD68 immunostaining permitted
to discard macrophages as the mainly interstitial cells indu-
ced by ligature, as only a very small number of these cells
were found positive for CD68. All these data together suggest
that most of interstitial cells appearing 3 days after obstruc-
tion present features of fibroblast–myofibroblasts.
Several works based on different animal models have
previously reported increased ERK1/2 activation in diseased
kidneys.18–22,27–29 Here we provide evidence for the increased
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Figure 8 | Renal detection of total Akt protein and Akt mRNA 3
days after surgery. (a) Representative western blot analysis
of total Akt expression in kidneys of sham-operated (SO),
contralateral non-ligated (NL), and ligated (L) groups 3 days after
surgery. (b) Expression of Akt mRNA detected by northern blot
analysis in kidneys of SO, NL, and L groups. Bars represent the
mean±s.e.m. of the optical density of signals (n¼ 4 and
7 samples per group in western and northern blot analysis,
respectively). *Po0.05 vs SO kidneys. Vehicle-control animals
received the solvent dimethyl sulfoxide (DMSO). U0126 and LY
294002 groups respectively received the corresponding inhibitors
of ERK1/2 and Akt activation, both dissolved in DMSO.
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expression of activated ERK1/2 in interstitial areas of kidneys
submitted to 3 days of UUO as immunohistochemical and
western blot analysis demonstrated. This work also demon-
strates that ureteral ligation induced a marked upregulation
of both Akt activation and Akt expression, as shown
respectively by western blot quantifying of pAkt, and western
and northern blot quantifying of total Akt. As revealed with
the strong pAkt immunostaining, normal proximal tubular
cell seems to be a main contributor to the obstruction-
induced activation of Akt measured by western blot. Our
findings suggest that the activation of Ras signaling pathway
is likely to be the cause of increased ERK1/2 and Akt
phosphorylation in obstructed kidneys, as we have observed
an increase in the ratio Ras-GTP/total Ras in the L kidneys
when compared with NL or SO kidneys.
Role of ERK1/2 activation in obstructed kidney
Extra-cellular signal-regulated kinase activation has been
related to proliferative response in rats with experimental
glomerulonephritis,19,20,29 as well as early proliferation of
tubular cells in a rat model of UUO.21,22 In agreement with
UUO studies performed in rat,21,22 we have reported a higher
activation of ERK1/2 in L than in NL kidneys as western blot
analysis demonstrated. Immunohistochemical analysis loca-
lized this pERK increase to cortical tubulointerstitial areas.
This finding is in agreement with a recent report of Zhang
et al.30, describing that transforming growth factor-b induces
ERK1/2 activation in cultured immortalized human proximal
tubular cells. Treatment with the MEK inhibitor induced a
moderate decrease in the number of proliferating interstitial
nuclei in L kidneys when compared with L kidneys of mice
receiving only the vehicle, whereas the number of proliferat-
ing tubular nuclei, though nonsignificant, was reduced to
50%. These data suggest that renal ERK1/2 signaling pathway
may partially contribute to early process of tubular cell
proliferation induced by obstruction.
In vitro models of oxidative renal injury demonstrated a
role for ERK activation in apoptosis of renal fibroblasts31 but
not in tubular epithelium where it promoted cell survival.28
In contrast with previous results, our data suggest that
ERK activation is involved in ligation-induced tubular cell
apoptosis as it may be deduced from the marked decrease
in the number of TUNEL-positive nuclei and the decreased
number of tubules as well as total interstitial area stained for
activated caspase-3 in L kidneys of U0126-treated mice. In
addition, affected tubules presented partial lower staining of
epithelial cells and better conservation of tubular structures
in contrast to DMSO-obstructed kidneys. It has been recently
reported that treatment with U0126 is able to decrease
cisplatin-induced tubular cell apoptosis either in vitro32 or
in vivo.33 Taking all these data together, it may be suggested
that MEK1/2–ERK1/2 signaling pathway is involved in
regulation of obstruction-induced tubular cell apoptosis.
Moreover, the reduced levels of interstitial apoptosis that
were detected in L kidneys after U0126 also contribute to
suggest an important role for ERK1/2 activation in initiating
the apoptotic cascade during early UUO. These data are in
agreement with previous studies demonstrating that inhibi-
tion of ERK1/2 activity in proximal tubular cells prevented
cellular apoptosis induced by deprivation of survival
factors.34
Administration of U0126 gives further proofs of ERK1/2
involvement in UUO-induced renal damage, as demonstrated
by the marked interstitial decrease in a-SMA and vimentin
expression detected in L kidneys treated with U0126 when
compared with L kidneys of untreated animals. Interstitial
cells expressing a-SMA have been related to profibrotic
activated fibroblasts at 3 days of UUO;4 however, the effect
of inhibiting ERK1/2 activation did not modify the increase
of interstitial fibronectin or collagen I in L kidneys. The
nonsignificant decrease detected in obstruction-induced
proliferation of interstitial cells after U0126 treatment may
be contributing to this fact. From these data, it could be
deduced that activation of MEK1/2–ERK1/2 cascade is
implicated in de novo appearance of myofibroblast-related
a-SMA- and vimentin-positive cells in the interstitium
of obstructed kidneys but, apparently, activated ERK1/2
does not modulate the increased interstitial production of
fibronectin and collagen I. Phosphorylation of MAPK–ERK1/
2 pathway seems also to mediate the initial signaling for
apoptotic cascade activation both in interstitium and in
tubular epithelium during early renal damage induced by
ureteral obstruction.
Role of Akt activation in obstructed kidney
Tubular apoptosis constitutes a typical feature of renal
damage in obstructed kidney,7 and the pAkt localization that
we have reported here may be associated with PI3K/Akt-
mediated survival mechanisms as the anti-apoptotic role of
Akt is well known.17 Further support to this hypothesis is
given by the fact that dilated tubules of L kidneys presented
reduced activity of Akt and increased staining for activated
caspase-3 as indicative of undergoing apoptosis. Moreover,
in vivo inhibition of PI3K–Akt signaling pathway resulted in
obstruction-induced increased damage of altered tubules,
although no effect on the number of tubular cells stained for
cleaved caspase-3 or in the abundance of TUNEL-labeled
nuclei was detected. In vitro experiments have also demon-
strated that Akt upregulation prevents apoptosis in proximal
tubular cells.34 Taking all these data together, it could be
suggested that Akt activation after obstruction plays an
important role against obstructive injury contributing to
survival signaling in renal tubules.
In addition, effects of PI3K inhibition on obstructed
interstitium, including the marked decrease in both a-SMA
and vimentin expression could result in decreased matrix
deposition as suggested by the diminished levels of interstitial
fibronectin and collagen I detected in L kidney. Akt activity
also appears to be implicated in early mechanisms of cell
proliferation in response to renal injury, as decreased levels of
Ki-67-positive stained cells were detected in both tubular
epithelia and interstitium of L kidney after LY 294002
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treatment. Further evidences of the involvement of the
PI3K–Akt signaling pathway in UUO-induced renal damage
have been given by a recent study reporting that LY 294002
reduced proliferation and extracellular matrix synthesis
in fibroblasts obtained from rat kidney tissue 3 days after
UUO.35 Furthermore, and also in close agreement with our
data, this study also reported that LY 294002 was not able to
modify fibroblast apoptosis.35 Therefore, early pharmaco-
logical downregulation of PI3K–Akt signaling pathway
reduces not only the profibrotic interstitial cells but also
the potential number of tubular cells that have been described
as responsible for excessive interstitial matrix production at
later stages of UUO.4 All these data suggest that activated Akt
plays an essential role in regulating renal cell proliferation, as
well as fibroblast activation and matrix production in the
interstitium of obstructed kidneys.
Perspectives
Our results identify a discrete pattern of activation of the Ras-
ERK1/2 and -Akt pathways in the kidneys of normal mice and
a marked activation of these pathways in kidneys of mice
subjected to UUO. As acquisition of mesenchymal features
for interstitial cells, such as a-SMA and vimentin, has been
related to production of interstitial matrix components at early
obstruction, the interstitial reduction for these markers
observed after U0126 or LY 294002 treatment indicates that
inhibition of either MAPK–ERK1/2 or PI3K–Akt signaling
pathways could result in an efficient strategy to reduce the
number of profibrotic interstitial cells during early fibrosis
induced by UUO. Furthermore, we provide evidence that
inhibition of PI3K markedly reduced the obstruction-induced
increase in both tubular and interstitial proliferating cells,
including the profibrotic fibroblast–myofibroblasts in accor-
dance with decreased levels of fibronectin and collagen I
detected in the renal interstitium of L kidneys in animals
receiving LY 294002. Our study also showed that administra-
tion of MEK inhibitor diminishes the increased levels of
tubular and interstitial cell apoptosis in obstructed kidneys,
and contributes to structural maintenance of renal tubules
providing, therefore, a novel strategy to protect epithelial
tubular cells from apoptotic renal damage and tubular atrophy
induced by obstructive nephropathy.
In conclusion, these results demonstrate that activation of
either ERK1/2 or Akt participates in initial changes during
early obstructive nephropathy. Pharmacological inhibition of
MAPK–ERK1/2 and PI3K–Akt signaling pathways could be a
potential target to reduce extracellular matrix deposition in the
interstitium of damage kidneys and, therefore, contributes to
prevent the development of progressive nephropathy.
MATERIALS AND METHODS
Animals and disease model
Surgical procedures were performed in 2-month-old C57BL/6J male
mice as previously described.36 Animals were kept under controlled
ambient conditions (Unidad de Experimentacio´n Animal, Univer-
sity of Salamanca, Spain). The first and third day after ligation,
a group of six animals received intraperitoneal administration of
U0126 (1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)-buta-
diene; LC Laboratories, PKC Pharmaceuticals Inc., Woburn, MA,
USA; no. U-6770; 25 mg/kg/day), which blocks ERK1/2 activation
by inhibiting both active and inactive MEK-1 and MEK-2.
Akt activation was blocked by intraperitoneal administration of
the PI3K inhibitor LY 294002 (2-(4-morpholino)-8-phenyl-4H-1-
benzopyran-4-one; LC Laboratories, PKC Pharmaceuticals Inc.; no.
L-7962) to a second group of six mice receiving the dose once daily
for 3 days after UUO (50 mg/kg/day). As B300 ml of DMSO was
required to dissolve each inhibitor, two additional groups of SO
(n¼ 3) and UUO mice (n¼ 4) received final equal amounts of this
vehicle for 3 days. SO animals (n¼ 7) and animals submitted to
3 days of UUO (n¼ 7) were included as respective control groups.
In all procedures, mice were treated in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
animals.
Renal tissue preparation
Kidneys of SO animals together with L and contralateral NL kidneys
of UUO mice were recovered 3 days after surgery. Renal samples of
animals destined for protein extraction were frozen in liquid
nitrogen and stored at 801C until use. Animals destined for
histological studies were perfused with heparinized saline solution-
4% buffered formalin. Kidneys were removed, halved longitudinally,
fixed for 24 h in 4% buffered formalin, and then embedded in
paraffin. Sections 3-mm thick were cut and mounted on glass slides
for immunohistochemical studies and TUNEL assay.
Affinity precipitation of Ras-GTP in renal tissue
Thirty milligrams of powdered kidney was lysed in 500 ml of buffer
containing 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid, pH 7.5; 150 mM NaCl, 1% igepal CA-630, 10 mM MgCl2,
1 mM EDTA, 10% g1ycerol, 1 mM Na3VO4, 25 mM NaF, l mM
phenylmethanesulfonylfluoride, 10 mg/ml aprotinin, and 10 mg/ml
1eupeptin. Lysates were cold centrifuged for 10 min at 4000 g and
the supernatant collected. Following measurement of protein
concentration (Biorad, Madrid, Spain), 2 mg of the total protein
was added to lysis buffer to yield a final sample volume of 300 ml.
Samples were incubated with 20mg of Raf-1 Ras-binding domain
agarose conjugate (Upstate biotechnology, Lake Placid, NY, USA;
no. 14–278) and gently rocked at 41C for 30 min. The agarose
conjugates were recovered by pulse centrifugation, washed three
times with 500 ml of lysis buffer, resuspended in 40 ml of Laemmli
sample buffer, and boiled for 5 min. Sample supernatants were
collected for use in western blot detection of Ras-GTP.
Western blot analyses
Affinity-precipitated samples described above were used for
Ras-GTP detection, whereas total kidney protein lysates (30 mg)
were employed in the detection of fibronectin, collagen I, a-SMA,
vimentin, caspase-3, total ERK1/2, pERK, total Akt, pAkt, and total
Ras. Samples were electrophoresed in 15% (Ras), 12% (ERK1/2,
a-SMA), 8% (Akt, vimentin, collagen I), or 6% (fibronectin)
sodium dodecyl sulfate-polyacrylamide gels and transferred to a
nitrocellulose membrane (0.45 mm; BioRad). Membranes were incu-
bated overnight at 41C with following antibodies: anti-Ras (1:1000
dilution; Upstate Biotechnology; no. 05–516), anti-ERK1 (1:1000
dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA; sc-94),
anti-pERK1/2 (1:2000 dilution; Santa Cruz Biotechnology; sc-7383),
anti-Akt1/2 (1:1000 dilution; Santa Cruz Biotechnology; sc-8312),
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anti-pAkt (1:1000 dilution; Cell Signaling Technology Inc., Danvers,
MA, USA; 9271S no. 172), anti a-SMA (1:1000 dilution; Sigma,
St Louis, MO, USA; A 2547), anti-vimentin (1:1000 dilution;
Santa Cruz Biotechnology; no. sc-7557), anti-collagen type I (1:1000
dilution; Chemicon International Inc., Ternecula, CA, USA;
AB765P), and anti-fibronectin (1:5000 dilution; Chemicon Interna-
tional Inc.; AB2033). After incubation with the corresponding
horseradish peroxidase-conjugated secondary antibody (1:10,000
dilution; BioRad), membranes were incubated with a chemi-
luminescent reagent (ECL detection reagents, Amersham, Buck-
inghamshire, UK) and developed signals recorded on X-ray film
(Hyperfilm, Amersham) for densitometric analysis (MacBAS, Fuji,
Japan). We have verified by western blot that renal levels of proteins
like b-actin or a-tubulin, usually employed as loading control,
increased in obstructed kidneys following equal loading of total
proteins measured (Supplementary Figure). We have then used total
ERK1/2 as loading control, as no renal changes were detected for
this protein after obstruction.
Northern blot analysis
Total kidney RNA was isolated using the guanidinium thiocyanate–
phenol–chloroform method, fractionated by electrophoresis (20 mg/
lane) in a denaturing 1% agarose-2.2 mol/l formaldehyde gel, and
transferred to a nylon membrane (Hybond, Amersham). The cDNA
probe used for Akt was a BamHI/BglII fragment of murine Akt
inserted into the pSG5 plasmid. Forty nanograms of probe were
radiolabeled with a-32P dCTP (3000 Ci/mmol). Results were
expressed as mRNA/28S relative optical density ratios.
Immunohistochemical studies
Immunohistochemistry was performed as previously described.36
Primary antibodies were anti-fibronectin (1:100 dilution; Sigma; no.
F 3648), anti-collagen I (1:200 dilution; Abcam, Cambridge, UK; no.
ab6308), anti-a-SMA (pre-diluted; DAKO Diagnostics, Copenha-
gen, Denmark; M0851), anti-vimentin (pre-diluted; Abcam; no.
ab8545), anti-CD68 (1:100 dilution; Clone KP1; DAKO Diagnostics;
no. M0814), anti-Ki-67 (1:100 dilution; Master Diagnostica,
Granada, Spain), anti-cleaved caspase-3 (1:200 dilution; Cell
Signaling Technology Inc.; no. 9661), anti-pERK1/2 (1:300 dilution;
Santa Cruz Biotechnology; sc-7383), or anti-pAkt (1:50 dilution,
Cell Signaling Technology Inc.; 9271S no. 172). Following washes in
phosphate-buffered saline, sections were incubated with DAKO LSAB2
system þHRP (DAKO), and 3,30-diaminobenzidine (BioGenex,
San Ramon, CA, USA) was used as chromogen. Samples lacking
primary antibody, were processed as negative controls.
Semiquantitative immunohistochemical determinations in
renal sections
Quantification of interstitial fibronectin, collagen I, a-SMA,
vimentin, or caspase-3 immunostaining was carried out in a blind
trial by using a computer-assisted method based on Visilog 6.5
Professional Imaging software (Noesis, France). At least, 30
consecutive fields of cortical renal interstitium were processed.
Automated analysis was performed on individual images saved as
24-bit RGB TIFF file format at Original magnification  20 by
using a specific Cþ þ language program. Our software first
transform color images to 256 grey levels, then divide up the image
into several areas using intensity of the immunostaining, and last
quantify those areas. Final score of each sample was calculated as a
mean of the whole scores obtained and expressed in square microns
per field.
Counting of renal cells expressing Ki-67 or cleaved caspase-3
The number of tubular or interstitial cells undergoing proliferation
(Ki-67-positive immunostaining) or tubular cells expressing the
principal executioner caspase of the apoptotic program (cleaved
caspase-3-positive immunostaining) was counted under light
microscopy at Original magnification  200 in 6–10 random fields
of renal cortex.
TUNEL assay in renal sections
TUNEL was performed using an in situ cell death detection kit
(Roche Molecular Biochemicals, Mannheim, Germany) according to
the manufacturer’s instructions. The TUNEL labeling was visualized
under fluorescence microscopy.
Statistical analysis
Statistical differences were analyzed by one-way analysis of variance
using the NCSS 2000 program. Scheffe’s correction test was
employed for multiple comparisons. Data were expressed as
mean±s.e.m., and Po0.05 was considered statistically significant.
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SUPPLEMENTARY MATERIAL
Figure. Representative western blot analysis of total ERK1/2, b-actin,
and a-tubulin expression in kidneys of sham-operated (SO), non-
ligated (NL), and ligated (L) groups 3 days after surgery (n¼ 4
samples per group).
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